Bluejay Diagnostics (BJDX) Treasury Shares (2020 - 2025)

Bluejay Diagnostics (BJDX) has 5 years of Treasury Shares data on file, last reported at $1.0 in Q1 2025.

• For the quarter ending Q1 2025, Treasury Shares fell 99.9% year-over-year to $1.0; the trailing twelve-month figure through Mar 2025 stood at $1.0 (down 99.9% YoY), and the FY2024 full-year result was $1.0, down 95.0% from the prior year.
• Treasury Shares held at $1.0 in Q1 2025, from $1.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $197500.0 in Q1 2023 to a low of $1.0 in Q4 2024.
• A 4-year average of $35124.4 and a median of $2000.0 in 2022 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares tumbled 58.04% in 2023 and plunged 99.9% in 2025, its largest moves.
• Tracing BJDX's Treasury Shares over 4 years: stood at $3000.0 in 2022, then tumbled by 99.33% to $20.0 in 2023, then plunged by 95.0% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025.
• Business Quant data shows BJDX's Treasury Shares at $1.0 in Q1 2025, $1.0 in Q4 2024, and $62.0 in Q3 2024.